25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

DR.REDDY'S LABORATORIES LTD.
Buy, Hold or Sell?

Let's analyze DR.REDDY'S LABORATORIES LTD. together

I guess you are interested in DR.REDDY'S LABORATORIES LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of DR.REDDY'S LABORATORIES LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about DR.REDDY'S LABORATORIES LTD.

I send you an email if I find something interesting about DR.REDDY'S LABORATORIES LTD..

1. Quick Overview

1.1. Quick analysis of DR.REDDY'S LABORATORIES LTD. (30 sec.)










1.2. What can you expect buying and holding a share of DR.REDDY'S LABORATORIES LTD.? (30 sec.)

How much money do you get?

How much money do you get?
INR0.09
When do you have the money?
1 year
How often do you get paid?
48.0%

What is your share worth?

Current worth
INR353.67
Expected worth in 1 year
INR412.94
How sure are you?
96.0%

+ What do you gain per year?

Total Gains per Share
INR67.24
Return On Investment
5.2%

For what price can you sell your share?

Current Price per Share
INR1,288.20
Expected price per share
INR1,213 - INR1,356
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of DR.REDDY'S LABORATORIES LTD. (5 min.)




Live pricePrice per Share (EOD)
INR1,288.20
Intrinsic Value Per Share
INR723.71 - INR858.65
Total Value Per Share
INR1,077.39 - INR1,212.33

2.2. Growth of DR.REDDY'S LABORATORIES LTD. (5 min.)




Is DR.REDDY'S LABORATORIES LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$3.5b$2.6b$570.7m17.5%

How much money is DR.REDDY'S LABORATORIES LTD. making?

Current yearPrevious yearGrowGrow %
Making money$165.4m$140.5m$24.8m15.1%
Net Profit Margin19.3%18.0%--

How much money comes from the company's main activities?

2.3. Financial Health of DR.REDDY'S LABORATORIES LTD. (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of DR.REDDY'S LABORATORIES LTD.?

Welcome investor! DR.REDDY'S LABORATORIES LTD.'s management wants to use your money to grow the business. In return you get a share of DR.REDDY'S LABORATORIES LTD..

First you should know what it really means to hold a share of DR.REDDY'S LABORATORIES LTD.. And how you can make/lose money.

Speculation

The Price per Share of DR.REDDY'S LABORATORIES LTD. is INR1,288. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of DR.REDDY'S LABORATORIES LTD..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in DR.REDDY'S LABORATORIES LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR353.67. Based on the TTM, the Book Value Change Per Share is INR14.82 per quarter. Based on the YOY, the Book Value Change Per Share is INR13.47 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR2.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of DR.REDDY'S LABORATORIES LTD..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.200.0%0.200.0%0.170.0%0.120.0%0.100.0%
Usd Book Value Change Per Share0.200.0%0.180.0%0.160.0%0.120.0%0.170.0%
Usd Dividend Per Share0.000.0%0.020.0%0.040.0%0.030.0%0.030.0%
Usd Total Gains Per Share0.200.0%0.200.0%0.200.0%0.150.0%0.200.0%
Usd Price Per Share76.23-71.24-54.58-55.78-50.87-
Price to Earnings Ratio95.84-90.00-82.12-329.96-327.05-
Price-to-Total Gains Ratio379.08-360.58-284.96-517.08-529.39-
Price to Book Ratio18.11-18.17-16.86-19.32-19.02-
Price-to-Total Gains Ratio379.08-360.58-284.96-517.08-529.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share15.32958
Number of shares65
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.03
Usd Book Value Change Per Share0.180.12
Usd Total Gains Per Share0.200.15
Gains per Quarter (65 shares)13.009.84
Gains per Year (65 shares)52.0139.36
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
16464283229
2129294156368
3191381462395107
42518319830127146
53122925038159185
63727530246190224
74332135453222263
84936740661254302
95641345869286341
106245851076317380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%24.01.00.096.0%24.01.00.096.0%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%22.03.00.088.0%22.03.00.088.0%
Dividend per Share1.00.03.025.0%5.00.07.041.7%9.00.011.045.0%12.00.013.048.0%12.00.013.048.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%24.01.00.096.0%24.01.00.096.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of DR.REDDY'S LABORATORIES LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--16.89814.815+14%13.466+25%10.260+65%14.147+19%
Book Value Per Share--353.674329.512+7%271.938+30%245.079+44%225.547+57%
Current Ratio--2.5472.566-1%2.371+7%2.085+22%1.939+31%
Debt To Asset Ratio--0.2910.279+4%0.281+4%0.314-8%0.341-15%
Debt To Equity Ratio--0.4100.387+6%0.390+5%0.462-11%0.497-18%
Dividend Per Share---1.995-100%2.988-100%2.462-100%2.545-100%
Eps--16.71016.686+0%14.180+18%10.131+65%8.807+90%
Free Cash Flow Per Share--2.4876.299-61%12.341-80%6.512-62%5.800-57%
Free Cash Flow To Equity Per Share--13.9408.033+74%0.307+4441%2.089+567%1.813+669%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--858.654--------
Intrinsic Value_10Y_min--723.714--------
Intrinsic Value_1Y_max--38.491--------
Intrinsic Value_1Y_min--37.779--------
Intrinsic Value_3Y_max--151.889--------
Intrinsic Value_3Y_min--144.275--------
Intrinsic Value_5Y_max--308.981--------
Intrinsic Value_5Y_min--283.669--------
Market Cap1073129877811.200-397%5336284600296.6024986936340411.802+7%3820734396463.001+40%3905076127857.231+37%3561158480788.953+50%
Net Profit Margin--0.1810.193-6%0.180+1%0.140+30%0.128+42%
Operating Margin----0%0.182-100%0.080-100%0.084-100%
Operating Ratio--1.1631.151+1%1.015+14%1.109+5%1.157+0%
Pb Ratio3.642-397%18.11218.1690%16.860+7%19.320-6%19.017-5%
Pe Ratio19.273-397%95.83889.996+6%82.122+17%329.963-71%327.047-71%
Price Per Share1288.200-397%6405.7505986.388+7%4586.463+40%4687.708+37%4274.864+50%
Price To Free Cash Flow Ratio129.480-397%643.857-746.783+216%-227.525+135%-283.429+144%-207.486+132%
Price To Total Gains Ratio76.233-397%379.078360.575+5%284.955+33%517.082-27%529.390-28%
Quick Ratio--1.6161.788-10%1.762-8%1.422+14%1.294+25%
Return On Assets--0.0340.037-9%0.038-11%0.029+16%0.026+31%
Return On Equity--0.0470.051-7%0.052-9%0.042+13%0.037+29%
Total Gains Per Share--16.89816.810+1%16.454+3%12.722+33%16.692+1%
Usd Book Value--3506061300.0003266535125.000+7%2695784350.000+30%2429526610.000+44%2235900520.000+57%
Usd Book Value Change Per Share--0.2010.176+14%0.160+25%0.122+65%0.168+19%
Usd Book Value Per Share--4.2093.921+7%3.236+30%2.916+44%2.684+57%
Usd Dividend Per Share---0.024-100%0.036-100%0.029-100%0.030-100%
Usd Eps--0.1990.199+0%0.169+18%0.121+65%0.105+90%
Usd Free Cash Flow--24656800.00062448225.000-61%122340925.000-80%64557500.000-62%57495564.000-57%
Usd Free Cash Flow Per Share--0.0300.075-61%0.147-80%0.077-62%0.069-57%
Usd Free Cash Flow To Equity Per Share--0.1660.096+74%0.004+4441%0.025+567%0.022+669%
Usd Market Cap12770245545.953-397%63501786743.53059344542450.901+7%45466739317.910+40%46470405921.501+37%42377785921.389+50%
Usd Price Per Share15.330-397%76.22871.238+7%54.579+40%55.784+37%50.871+50%
Usd Profit--165648000.000165412975.000+0%140518175.000+18%104913375.000+58%90885060.000+82%
Usd Revenue--913051300.000858974725.000+6%779292325.000+17%704541880.000+30%648444328.000+41%
Usd Total Gains Per Share--0.2010.200+1%0.196+3%0.151+33%0.199+1%
 EOD+4 -4MRQTTM+18 -16YOY+19 -165Y+25 -1010Y+25 -10

3.3 Fundamental Score

Let's check the fundamental score of DR.REDDY'S LABORATORIES LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1519.273
Price to Book Ratio (EOD)Between0-13.642
Net Profit Margin (MRQ)Greater than00.181
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.616
Current Ratio (MRQ)Greater than12.547
Debt to Asset Ratio (MRQ)Less than10.291
Debt to Equity Ratio (MRQ)Less than10.410
Return on Equity (MRQ)Greater than0.150.047
Return on Assets (MRQ)Greater than0.050.034
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of DR.REDDY'S LABORATORIES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.490
Ma 20Greater thanMa 501,301.919
Ma 50Greater thanMa 1001,321.540
Ma 100Greater thanMa 2001,329.153
OpenGreater thanClose1,299.450
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About DR.REDDY'S LABORATORIES LTD.

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Fundamental data was last updated by Penke on 2024-10-29 01:14:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit DR.REDDY'S LABORATORIES LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare DR.REDDY'S LABORATORIES LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 18.1% means that ₹0.18 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 18.1%. The company is making a huge profit. +2
  • The TTM is 19.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ18.1%TTM19.3%-1.2%
TTM19.3%YOY18.0%+1.3%
TTM19.3%5Y14.0%+5.3%
5Y14.0%10Y12.8%+1.2%
4.3.1.2. Return on Assets

Shows how efficient DR.REDDY'S LABORATORIES LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare DR.REDDY'S LABORATORIES LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.4% Return on Assets means that DR.REDDY'S LABORATORIES LTD. generated ₹0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 3.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.4%TTM3.7%-0.3%
TTM3.7%YOY3.8%-0.1%
TTM3.7%5Y2.9%+0.8%
5Y2.9%10Y2.6%+0.3%
4.3.1.3. Return on Equity

Shows how efficient DR.REDDY'S LABORATORIES LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare DR.REDDY'S LABORATORIES LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.7% Return on Equity means DR.REDDY'S LABORATORIES LTD. generated ₹0.05 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 4.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 5.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.7%TTM5.1%-0.4%
TTM5.1%YOY5.2%-0.1%
TTM5.1%5Y4.2%+0.9%
5Y4.2%10Y3.7%+0.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of DR.REDDY'S LABORATORIES LTD..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient DR.REDDY'S LABORATORIES LTD. is operating .

  • Measures how much profit DR.REDDY'S LABORATORIES LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare DR.REDDY'S LABORATORIES LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY18.2%-18.2%
TTM-5Y8.0%-8.0%
5Y8.0%10Y8.4%-0.4%
4.3.2.2. Operating Ratio

Measures how efficient DR.REDDY'S LABORATORIES LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.16 means that the operating costs are ₹1.16 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 1.163. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.151. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.163TTM1.151+0.012
TTM1.151YOY1.015+0.136
TTM1.1515Y1.109+0.042
5Y1.10910Y1.157-0.048
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of DR.REDDY'S LABORATORIES LTD..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if DR.REDDY'S LABORATORIES LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.55 means the company has ₹2.55 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 2.547. The company is able to pay all its short-term debts. +1
  • The TTM is 2.566. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.547TTM2.566-0.019
TTM2.566YOY2.371+0.195
TTM2.5665Y2.085+0.482
5Y2.08510Y1.939+0.146
4.4.3.2. Quick Ratio

Measures if DR.REDDY'S LABORATORIES LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare DR.REDDY'S LABORATORIES LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.62 means the company can pay off ₹1.62 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 1.616. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.788. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.616TTM1.788-0.172
TTM1.788YOY1.762+0.026
TTM1.7885Y1.422+0.367
5Y1.42210Y1.294+0.128
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of DR.REDDY'S LABORATORIES LTD..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of DR.REDDY'S LABORATORIES LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare DR.REDDY'S LABORATORIES LTD. to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.29 means that DR.REDDY'S LABORATORIES LTD. assets are financed with 29.1% credit (debt) and the remaining percentage (100% - 29.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 0.291. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.279. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.291TTM0.279+0.012
TTM0.279YOY0.281-0.002
TTM0.2795Y0.314-0.035
5Y0.31410Y0.341-0.027
4.5.4.2. Debt to Equity Ratio

Measures if DR.REDDY'S LABORATORIES LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare DR.REDDY'S LABORATORIES LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 41.0% means that company has ₹0.41 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 0.410. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.387. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.410TTM0.387+0.023
TTM0.387YOY0.390-0.003
TTM0.3875Y0.462-0.074
5Y0.46210Y0.497-0.035
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings DR.REDDY'S LABORATORIES LTD. generates.

  • Above 15 is considered overpriced but always compare DR.REDDY'S LABORATORIES LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 95.84 means the investor is paying ₹95.84 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of DR.REDDY'S LABORATORIES LTD.:

  • The EOD is 19.273. Based on the earnings, the company is fair priced.
  • The MRQ is 95.838. Based on the earnings, the company is expensive. -2
  • The TTM is 89.996. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD19.273MRQ95.838-76.565
MRQ95.838TTM89.996+5.843
TTM89.996YOY82.122+7.874
TTM89.9965Y329.963-239.967
5Y329.96310Y327.047+2.916
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of DR.REDDY'S LABORATORIES LTD.:

  • The EOD is 129.480. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 643.857. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -746.783. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD129.480MRQ643.857-514.377
MRQ643.857TTM-746.783+1,390.640
TTM-746.783YOY-227.525-519.258
TTM-746.7835Y-283.429-463.354
5Y-283.42910Y-207.486-75.943
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of DR.REDDY'S LABORATORIES LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 18.11 means the investor is paying ₹18.11 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of DR.REDDY'S LABORATORIES LTD.:

  • The EOD is 3.642. Based on the equity, the company is fair priced.
  • The MRQ is 18.112. Based on the equity, the company is expensive. -2
  • The TTM is 18.169. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD3.642MRQ18.112-14.470
MRQ18.112TTM18.169-0.057
TTM18.169YOY16.860+1.309
TTM18.1695Y19.320-1.151
5Y19.32010Y19.017+0.303
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in INR. All numbers in thousands.

Summary
Total Assets415,297,000
Total Liabilities120,670,000
Total Stockholder Equity294,627,000
 As reported
Total Liabilities 120,670,000
Total Stockholder Equity+ 294,627,000
Total Assets = 415,297,000

Assets

Total Assets415,297,000
Total Current Assets269,188,000
Long-term Assets146,109,000
Total Current Assets
Cash And Cash Equivalents 4,913,000
Short-term Investments 89,713,000
Net Receivables 81,088,000
Inventory 68,568,000
Other Current Assets 24,483,000
Total Current Assets  (as reported)269,188,000
Total Current Assets  (calculated)268,765,000
+/- 423,000
Long-term Assets
Property Plant Equipment 80,343,000
Goodwill 4,243,000
Long Term Investments 5,209,000
Intangible Assets 37,131,000
Long-term Assets Other 1,659,000
Long-term Assets  (as reported)146,109,000
Long-term Assets  (calculated)128,585,000
+/- 17,524,000

Liabilities & Shareholders' Equity

Total Current Liabilities105,673,000
Long-term Liabilities14,997,000
Total Stockholder Equity294,627,000
Total Current Liabilities
Short Long Term Debt 23,165,000
Accounts payable 34,109,000
Other Current Liabilities 36,789,000
Total Current Liabilities  (as reported)105,673,000
Total Current Liabilities  (calculated)94,063,000
+/- 11,610,000
Long-term Liabilities
Long term Debt 3,800,000
Capital Lease Obligations Min Short Term Debt3,710,000
Long-term Liabilities Other 3,922,000
Long-term Liabilities  (as reported)14,997,000
Long-term Liabilities  (calculated)11,432,000
+/- 3,565,000
Total Stockholder Equity
Retained Earnings 279,264,000
Total Stockholder Equity (as reported)294,627,000
Total Stockholder Equity (calculated)279,264,000
+/- 15,363,000
Other
Capital Stock834,000
Common Stock Shares Outstanding 166,545
Net Debt 22,052,000
Net Invested Capital 321,592,000
Net Working Capital 163,515,000



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
227,188,000
219,821,000
218,387,000
222,018,000
225,956,000
233,142,000
217,898,000
232,253,000
251,243,000
253,802,000
252,346,000
266,168,000
278,214,000
279,210,000
282,499,000
297,469,000
295,975,000
291,689,000
309,300,000
322,851,000
335,041,000
348,094,000
372,842,000
387,518,000
415,297,000
415,297,000387,518,000372,842,000348,094,000335,041,000322,851,000309,300,000291,689,000295,975,000297,469,000282,499,000279,210,000278,214,000266,168,000252,346,000253,802,000251,243,000232,253,000217,898,000233,142,000225,956,000222,018,000218,387,000219,821,000227,188,000
   > Total Current Assets 
105,363,000
100,375,000
100,007,000
103,008,000
109,491,000
120,085,000
117,254,000
130,370,000
132,937,000
132,800,000
133,418,000
145,503,000
158,776,000
160,098,000
166,829,000
177,823,000
179,708,000
175,606,000
194,487,000
204,255,000
210,259,000
217,397,000
238,477,000
248,049,000
269,188,000
269,188,000248,049,000238,477,000217,397,000210,259,000204,255,000194,487,000175,606,000179,708,000177,823,000166,829,000160,098,000158,776,000145,503,000133,418,000132,800,000132,937,000130,370,000117,254,000120,085,000109,491,000103,008,000100,007,000100,375,000105,363,000
       Cash And Cash Equivalents 
6,031,000
3,866,000
2,825,000
2,460,000
2,010,000
3,012,000
2,244,000
2,053,000
4,400,000
3,889,000
4,321,000
14,829,000
8,168,000
9,980,000
21,976,000
14,852,000
6,018,000
9,096,000
6,259,000
5,779,000
6,017,000
13,391,000
7,342,000
7,107,000
4,913,000
4,913,0007,107,0007,342,00013,391,0006,017,0005,779,0006,259,0009,096,0006,018,00014,852,00021,976,0009,980,0008,168,00014,829,0004,321,0003,889,0004,400,0002,053,0002,244,0003,012,0002,010,0002,460,0002,825,0003,866,0006,031,000
       Short-term Investments 
14,114,000
14,270,000
11,748,000
14,333,000
19,948,000
25,540,000
17,505,000
23,687,000
23,291,000
21,154,000
11,530,000
21,602,000
20,331,000
16,721,000
13,224,000
31,087,000
28,324,000
21,215,000
42,241,000
60,969,000
53,032,000
58,972,000
65,015,000
74,363,000
89,713,000
89,713,00074,363,00065,015,00058,972,00053,032,00060,969,00042,241,00021,215,00028,324,00031,087,00013,224,00016,721,00020,331,00021,602,00011,530,00021,154,00023,291,00023,687,00017,505,00025,540,00019,948,00014,333,00011,748,00014,270,00014,114,000
       Net Receivables 
42,724,000
44,999,000
44,657,000
45,931,000
46,471,000
43,649,000
47,394,000
57,309,000
49,069,000
50,077,000
53,165,000
49,641,000
61,022,000
68,611,000
62,446,000
66,764,000
73,214,000
80,052,000
77,338,000
75,770,000
77,248,000
69,722,000
78,417,000
80,298,000
81,088,000
81,088,00080,298,00078,417,00069,722,00077,248,00075,770,00077,338,00080,052,00073,214,00066,764,00062,446,00068,611,00061,022,00049,641,00053,165,00050,077,00049,069,00057,309,00047,394,00043,649,00046,471,00045,931,00044,657,00044,999,00042,724,000
       Inventory 
30,052,000
28,529,000
28,095,000
26,998,000
26,825,000
35,033,000
37,746,000
35,066,000
39,148,000
41,134,000
44,309,000
45,412,000
50,771,000
49,700,000
49,675,000
50,884,000
51,810,000
49,042,000
49,326,000
48,670,000
52,398,000
56,592,000
60,796,000
63,552,000
68,568,000
68,568,00063,552,00060,796,00056,592,00052,398,00048,670,00049,326,00049,042,00051,810,00050,884,00049,675,00049,700,00050,771,00045,412,00044,309,00041,134,00039,148,00035,066,00037,746,00035,033,00026,825,00026,998,00028,095,00028,529,00030,052,000
       Other Current Assets 
12,442,000
7,999,000
12,682,000
13,286,000
14,237,000
12,851,000
12,365,000
11,305,000
17,029,000
13,736,000
16,059,000
14,019,000
15,042,000
15,086,000
13,995,000
14,236,000
16,206,000
18,937,000
19,323,000
19,251,000
20,353,000
18,572,000
4,215,000
2,771,000
24,483,000
24,483,0002,771,0004,215,00018,572,00020,353,00019,251,00019,323,00018,937,00016,206,00014,236,00013,995,00015,086,00015,042,00014,019,00016,059,00013,736,00017,029,00011,305,00012,365,00012,851,00014,237,00013,286,00012,682,0007,999,00012,442,000
   > Long-term Assets 
0
0
0
0
0
113,776,000
100,644,000
101,871,000
118,306,000
118,371,000
118,928,000
117,242,000
119,438,000
115,228,000
115,670,000
110,971,000
116,267,000
115,368,000
114,813,000
118,596,000
124,782,000
129,327,000
134,365,000
139,469,000
146,109,000
146,109,000139,469,000134,365,000129,327,000124,782,000118,596,000114,813,000115,368,000116,267,000110,971,000115,670,000115,228,000119,438,000117,242,000118,928,000118,371,000118,306,000101,871,000100,644,000113,776,00000000
       Property Plant Equipment 
0
57,160,000
57,611,000
57,905,000
58,189,000
53,008,000
52,709,000
52,332,000
54,183,000
54,737,000
0
56,861,000
0
59,939,000
0
61,665,000
0
63,817,000
64,996,000
56,542,000
67,207,000
70,478,000
72,795,000
76,886,000
80,343,000
80,343,00076,886,00072,795,00070,478,00067,207,00056,542,00064,996,00063,817,000061,665,000059,939,000056,861,000054,737,00054,183,00052,332,00052,709,00053,008,00058,189,00057,905,00057,611,00057,160,0000
       Goodwill 
3,789,000
3,752,000
3,824,000
3,883,000
3,870,000
4,605,000
3,939,000
4,913,000
4,817,000
5,626,000
4,634,000
5,599,000
4,615,000
5,614,000
4,546,000
5,473,000
4,381,000
5,224,000
4,495,000
5,474,000
4,238,000
5,410,000
4,287,000
4,253,000
4,243,000
4,243,0004,253,0004,287,0005,410,0004,238,0005,474,0004,495,0005,224,0004,381,0005,473,0004,546,0005,614,0004,615,0005,599,0004,634,0005,626,0004,817,0004,913,0003,939,0004,605,0003,870,0003,883,0003,824,0003,752,0003,789,000
       Long Term Investments 
7,389,000
6,840,000
5,366,000
4,831,000
5,014,000
4,217,000
3,278,000
3,091,000
3,387,000
3,992,000
8,632,000
8,333,000
9,496,000
7,489,000
6,491,000
7,986,000
5,214,000
6,107,000
6,279,000
6,089,000
4,904,000
5,924,000
8,333,000
5,255,000
5,209,000
5,209,0005,255,0008,333,0005,924,0004,904,0006,089,0006,279,0006,107,0005,214,0007,986,0006,491,0007,489,0009,496,0008,333,0008,632,0003,992,0003,387,0003,091,0003,278,0004,217,0005,014,0004,831,0005,366,0006,840,0007,389,000
       Intangible Assets 
0
44,925,000
44,740,000
45,751,000
44,312,000
39,222,000
26,908,000
26,798,000
41,174,000
40,394,000
36,428,000
35,248,000
35,131,000
32,329,000
32,035,000
27,011,000
31,832,000
31,589,000
30,906,000
30,724,000
38,068,000
36,993,000
36,905,000
36,951,000
37,131,000
37,131,00036,951,00036,905,00036,993,00038,068,00030,724,00030,906,00031,589,00031,832,00027,011,00032,035,00032,329,00035,131,00035,248,00036,428,00040,394,00041,174,00026,798,00026,908,00039,222,00044,312,00045,751,00044,740,00044,925,0000
       Other Assets 
0
6,769,000
6,839,000
6,640,000
5,080,000
12,211,000
13,810,000
14,795,000
14,745,000
13,026,000
0
10,993,000
0
9,745,000
0
13,399,000
0
9,360,000
8,137,000
7,328,000
10,365,000
11,324,000
0
0
0
00011,324,00010,365,0007,328,0008,137,0009,360,000013,399,00009,745,000010,993,000013,026,00014,745,00014,795,00013,810,00012,211,0005,080,0006,640,0006,839,0006,769,0000
> Total Liabilities 
106,148,000
95,777,000
94,964,000
100,178,000
102,271,000
79,026,000
69,226,000
76,265,000
89,495,000
87,128,000
82,951,000
89,751,000
100,100,000
93,766,000
92,483,000
105,345,000
95,586,000
83,937,000
89,027,000
89,990,000
89,781,000
93,126,000
104,992,000
106,968,000
120,670,000
120,670,000106,968,000104,992,00093,126,00089,781,00089,990,00089,027,00083,937,00095,586,000105,345,00092,483,00093,766,000100,100,00089,751,00082,951,00087,128,00089,495,00076,265,00069,226,00079,026,000102,271,000100,178,00094,964,00095,777,000106,148,000
   > Total Current Liabilities 
95,281,000
85,000,000
65,520,000
70,339,000
73,198,000
61,176,000
64,694,000
72,814,000
79,884,000
78,007,000
73,872,000
81,038,000
91,525,000
85,259,000
83,654,000
97,658,000
90,791,000
80,031,000
84,383,000
85,721,000
80,767,000
84,065,000
93,600,000
96,039,000
105,673,000
105,673,00096,039,00093,600,00084,065,00080,767,00085,721,00084,383,00080,031,00090,791,00097,658,00083,654,00085,259,00091,525,00081,038,00073,872,00078,007,00079,884,00072,814,00064,694,00061,176,00073,198,00070,339,00065,520,00085,000,00095,281,000
       Short-term Debt 
57,999,000
49,185,000
50,462,000
53,667,000
54,911,000
10,308,000
0
16,532,000
0
19,953,000
0
23,145,000
0
23,380,000
0
27,082,000
0
0
0
0
0
0
0
0
0
00000000027,082,000023,380,000023,145,000019,953,000016,532,000010,308,00054,911,00053,667,00050,462,00049,185,00057,999,000
       Short Long Term Debt 
57,999,000
49,185,000
50,462,000
53,667,000
54,911,000
15,621,000
14,467,000
20,315,000
24,049,000
19,953,000
13,110,000
23,145,000
26,299,000
23,380,000
21,331,000
27,082,000
21,701,000
14,573,000
15,268,000
12,194,000
6,468,000
5,851,000
12,343,000
12,723,000
23,165,000
23,165,00012,723,00012,343,0005,851,0006,468,00012,194,00015,268,00014,573,00021,701,00027,082,00021,331,00023,380,00026,299,00023,145,00013,110,00019,953,00024,049,00020,315,00014,467,00015,621,00054,911,00053,667,00050,462,00049,185,00057,999,000
       Accounts payable 
13,308,000
13,417,000
13,225,000
14,193,000
14,575,000
15,434,000
17,810,000
10,745,000
19,038,000
22,833,000
23,072,000
12,696,000
28,607,000
25,552,000
24,492,000
15,971,000
25,052,000
22,778,000
26,023,000
17,857,000
27,682,000
30,485,000
31,113,000
21,547,000
34,109,000
34,109,00021,547,00031,113,00030,485,00027,682,00017,857,00026,023,00022,778,00025,052,00015,971,00024,492,00025,552,00028,607,00012,696,00023,072,00022,833,00019,038,00010,745,00017,810,00015,434,00014,575,00014,193,00013,225,00013,417,00013,308,000
       Other Current Liabilities 
29,691,000
8,910,000
26,393,000
27,431,000
28,173,000
29,481,000
31,810,000
12,819,000
36,053,000
29,927,000
31,530,000
2,385,000
30,872,000
30,999,000
31,435,000
2,503,000
36,666,000
41,759,000
42,154,000
17,078,000
45,495,000
3,118,000
3,259,000
6,034,000
36,789,000
36,789,0006,034,0003,259,0003,118,00045,495,00017,078,00042,154,00041,759,00036,666,0002,503,00031,435,00030,999,00030,872,0002,385,00031,530,00029,927,00036,053,00012,819,00031,810,00029,481,00028,173,00027,431,00026,393,0008,910,00029,691,000
   > Long-term Liabilities 
0
0
0
0
0
18,869,000
4,532,000
4,439,000
9,611,000
9,471,000
9,079,000
9,038,000
8,575,000
8,670,000
8,829,000
8,285,000
4,795,000
4,718,000
4,644,000
4,269,000
9,014,000
9,753,000
11,392,000
10,929,000
14,997,000
14,997,00010,929,00011,392,0009,753,0009,014,0004,269,0004,644,0004,718,0004,795,0008,285,0008,829,0008,670,0008,575,0009,038,0009,079,0009,471,0009,611,0004,439,0004,532,00018,869,00000000
       Long term Debt Total 
0
0
0
0
0
15,284,000
0
1,304,000
0
6,661,000
0
6,299,000
0
5,977,000
0
5,746,000
0
1,795,000
0
1,278,000
0
6,043,000
0
0
0
0006,043,00001,278,00001,795,00005,746,00005,977,00006,299,00006,661,00001,304,000015,284,00000000
       Other Liabilities 
0
5,328,000
4,884,000
4,887,000
4,612,000
3,585,000
3,286,000
3,135,000
2,822,000
2,810,000
0
0
0
0
0
0
0
2,923,000
3,187,000
0
4,084,000
0
0
0
0
00004,084,00003,187,0002,923,00000000002,810,0002,822,0003,135,0003,286,0003,585,0004,612,0004,887,0004,884,0005,328,0000
> Total Stockholder Equity
0
124,044,000
123,423,000
121,840,000
123,685,000
154,116,000
148,672,000
155,988,000
161,748,000
166,674,000
169,395,000
176,417,000
178,114,000
185,444,000
190,016,000
192,124,000
200,389,000
207,752,000
220,273,000
232,861,000
245,259,000
254,968,000
267,850,000
280,550,000
294,627,000
294,627,000280,550,000267,850,000254,968,000245,259,000232,861,000220,273,000207,752,000200,389,000192,124,000190,016,000185,444,000178,114,000176,417,000169,395,000166,674,000161,748,000155,988,000148,672,000154,116,000123,685,000121,840,000123,423,000124,044,0000
   Common Stock
8,158,000
829,000
829,000
829,000
829,000
831,000
831,000
831,000
831,000
831,000
0
832,000
0
832,000
0
832,000
0
832,000
833,000
833,000
0
834,000
0
0
0
000834,0000833,000833,000832,0000832,0000832,0000832,0000831,000831,000831,000831,000831,000829,000829,000829,000829,0008,158,000
   Retained Earnings Total Equity0000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,688,000
0
0
0
0
0
000009,688,0000000000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
0
7,632,000
6,451,000
5,804,000
4,268,000
3,266,000
3,770,000
2,421,000
3,139,000
3,245,000
0
0
0
0
0
0
0
2,998,000
4,298,000
3,055,000
0
0
0
0
0
000003,055,0004,298,0002,998,00000000003,245,0003,139,0002,421,0003,770,0003,266,0004,268,0005,804,0006,451,0007,632,0000



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue279,164,000
Cost of Revenue-115,557,000
Gross Profit163,607,000163,607,000
 
Operating Income (+$)
Gross Profit163,607,000
Operating Expense-213,856,000
Operating Income65,308,000-50,249,000
 
Operating Expense (+$)
Research Development22,873,000
Selling General Administrative77,201,000
Selling And Marketing Expenses0
Operating Expense213,856,000100,074,000
 
Net Interest Income (+$)
Interest Income2,278,000
Interest Expense-1,711,000
Other Finance Cost-0
Net Interest Income567,000
 
Pretax Income (+$)
Operating Income65,308,000
Net Interest Income567,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)71,870,00059,313,000
EBIT - interestExpense = -1,711,000
55,684,000
57,395,000
Interest Expense1,711,000
Earnings Before Interest and Taxes (EBIT)073,581,000
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax71,870,000
Tax Provision-16,186,000
Net Income From Continuing Ops55,684,00055,684,000
Net Income55,684,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net5,995,000-567,000
 

Technical Analysis of DR.REDDY'S LABORATORIES LTD.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of DR.REDDY'S LABORATORIES LTD.. The general trend of DR.REDDY'S LABORATORIES LTD. is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine DR.REDDY'S LABORATORIES LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of DR.REDDY'S LABORATORIES LTD..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1,297 < 1,352 < 1,356.

The bearish price targets are: 1,240 > 1,224 > 1,213.

Tweet this
DR.REDDY'S LABORATORIES LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of DR.REDDY'S LABORATORIES LTD.. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

DR.REDDY'S LABORATORIES LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of DR.REDDY'S LABORATORIES LTD.. The current macd is -13.86248976.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the DR.REDDY'S LABORATORIES LTD. price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for DR.REDDY'S LABORATORIES LTD.. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the DR.REDDY'S LABORATORIES LTD. price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
DR.REDDY'S LABORATORIES LTD. Daily Moving Average Convergence/Divergence (MACD) ChartDR.REDDY'S LABORATORIES LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of DR.REDDY'S LABORATORIES LTD.. The current adx is 27.68.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell DR.REDDY'S LABORATORIES LTD. shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
DR.REDDY'S LABORATORIES LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of DR.REDDY'S LABORATORIES LTD.. The current sar is 1,220.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
DR.REDDY'S LABORATORIES LTD. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of DR.REDDY'S LABORATORIES LTD.. The current rsi is 45.49. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
DR.REDDY'S LABORATORIES LTD. Daily Relative Strength Index (RSI) ChartDR.REDDY'S LABORATORIES LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of DR.REDDY'S LABORATORIES LTD.. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the DR.REDDY'S LABORATORIES LTD. price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
DR.REDDY'S LABORATORIES LTD. Daily Stochastic Oscillator ChartDR.REDDY'S LABORATORIES LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of DR.REDDY'S LABORATORIES LTD.. The current cci is -43.19403574.

DR.REDDY'S LABORATORIES LTD. Daily Commodity Channel Index (CCI) ChartDR.REDDY'S LABORATORIES LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of DR.REDDY'S LABORATORIES LTD.. The current cmo is -5.25112644.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
DR.REDDY'S LABORATORIES LTD. Daily Chande Momentum Oscillator (CMO) ChartDR.REDDY'S LABORATORIES LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of DR.REDDY'S LABORATORIES LTD.. The current willr is -39.29583153.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that DR.REDDY'S LABORATORIES LTD. is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
DR.REDDY'S LABORATORIES LTD. Daily Williams %R ChartDR.REDDY'S LABORATORIES LTD. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of DR.REDDY'S LABORATORIES LTD..

DR.REDDY'S LABORATORIES LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of DR.REDDY'S LABORATORIES LTD.. The current atr is 34.00.

DR.REDDY'S LABORATORIES LTD. Daily Average True Range (ATR) ChartDR.REDDY'S LABORATORIES LTD. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of DR.REDDY'S LABORATORIES LTD.. The current obv is -1,017,582.

DR.REDDY'S LABORATORIES LTD. Daily On-Balance Volume (OBV) ChartDR.REDDY'S LABORATORIES LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of DR.REDDY'S LABORATORIES LTD.. The current mfi is 43.45.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
DR.REDDY'S LABORATORIES LTD. Daily Money Flow Index (MFI) ChartDR.REDDY'S LABORATORIES LTD. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for DR.REDDY'S LABORATORIES LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-13ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-23ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-25ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-31RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

DR.REDDY'S LABORATORIES LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of DR.REDDY'S LABORATORIES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.490
Ma 20Greater thanMa 501,301.919
Ma 50Greater thanMa 1001,321.540
Ma 100Greater thanMa 2001,329.153
OpenGreater thanClose1,299.450
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of DR.REDDY'S LABORATORIES LTD. with someone you think should read this too:
  • Are you bullish or bearish on DR.REDDY'S LABORATORIES LTD.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about DR.REDDY'S LABORATORIES LTD.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about DR.REDDY'S LABORATORIES LTD.

I send you an email if I find something interesting about DR.REDDY'S LABORATORIES LTD..


Comments

How you think about this?

Leave a comment

Stay informed about DR.REDDY'S LABORATORIES LTD..

Receive notifications about DR.REDDY'S LABORATORIES LTD. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.